Non-myeloablative mixed chimerism approaches and tolerance, a split decision

European Journal of Immunology

Volumn 37, Issue 5, 2007, Pages 1233-1242

  Luo, Bin ^a   Chan, William F N ^a   Shapiro, A M James ^a   Anderson, Colin C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chimerism; T cells; Tolerance; Transplantation

Indexed keywords

BUSULFAN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD40 LIGAND MONOCLONAL ANTIBODY; CELL ANTIGEN; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD8; MR 1; OKT 4; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; HEMATOPOIETIC CELL; IRRADIATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SKIN TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD; CHIMERA; CHIMERISM; FLOW CYTOMETRY; GRAFT REJECTION; MICE; POLYMORPHISM, GENETIC; SKIN TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 34250314882     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636938     Document Type: Article

References (58)

1. Williams, M. A., Trambley, J., Ha, J., Adams, A. B., Durham, M. M., Rees, P., Cowan, S. R. et al., Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol. 2000. 165: 6849-6857.
2. Anderson, C. C., Conceptual models in immunity/tolerance: Application to transplantation.In Wilkes, D. S. and Burlingham, W. J. (Eds.) Immunobiology of Organ Transplantation. Kluwer Academic/ Plenum Publishers, New York 2004, pp 171-190.
3. Owen, R. D., Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945. 102: 400-401.
4. Billingham, R. E., Brent, L. and Medawar, P. B., 'Actively acquired tolerance' of foreign cells. Nature 1953. 172: 603-606.
5. Starzl, T. E. and Zinkernagel, R. M., Transplantation tolerance from a historical perspective. Nat. Rev. Immunol. 2001. 1: 233-239.
6. Cosimi, A. B. and Sachs, D. H., Mixed chimerism and transplantation tolerance. Transplantation 2004. 77: 943-946.
7. Ildstad, S. T., Wren, S. M., Bluestone, J. A., Barbieri, S. A. and Sachs, D. H., Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 1985. 162: 231-244.
8. Billingham, R. E. and Brent, L., Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Phil. Trans. Roy. Soc. London Ser. B 1959. 242: 439-477.
9. Billingham, R. E. and Silvers, W. K., Some factors that determine the ability of cellular inocula to induce tolerance of tissue homografts. J. Cell. Comp. Physiol. 1962. 60: 183-200.
10. Brent, L. and Courtenay, T. H., On the induction of split tolerance.In Hasek, M., Lengerova, A. and Vojtiskova, M. (Eds.) Mechanisms of tolerance.Czechoslovakia Academy of Sciences, Prague 1962, pp 113.
11. Jackman, S. H., Boyse, E. A. and Goldberg, E. H., Adoptive transfer of skin-selective autoinummity induced by Skn alloantigenic disparities. Proc. Natl. Acad. Sci. USA 1992. 89: 11041-11045.
12. Emery, D. and McCullagh, P., Immunological reactivity between chimeric cattle twins. I. Homograft reaction. Transplantation 1980. 29: 4-9.
13. Metzler, B., Gfeller, P., Bigaud, M., Li, J., Wieczorek, G., Heusser, C., Lake, P. and Katopodis, A., Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J. Immunol. 2004. 173: 7025-7036.
14. Sharabi, Y. and Sachs, D. H., Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 1989. 169: 493-502.
15. Sykes, M., Szot, G. L., Swenson, K. A. and Pearson, D. A., Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat. Med. 1997 3: 783-787.
16. Tomita, Y., Yoshikawa, M., Zhang, Q. W., Shimizu, I., Okano, S., Iwai, T., Yasui, H. and Nomoto, K., Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide. J. Immunol. 2000. 165: 34-41.
17. Li, H., Inverardi, L., Molano, R. D., Pileggi, A. and Ricordi, C., Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Transplantation 2003. 75: 966-970.
18. Ildstad, S. T. and Sachs, D. H., Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984. 307: 168-170.
19. Luo, B., Nanji, S. A., Schur, C. D., Pawlick, R. L., Anderson, C. C. and Shapiro, A. M., Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation 2005. 80: 370-377.
20. -mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp. Hematol. 2004. 32: 861-867.
21. Cobbold, S. P., Martin, G., Qin, S. and Waldmann, H., Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986. 323: 164-166.
22. Leong, L. Y., Qin, S., Cobbold, S. P. and Waldmann, H., Classical transplantation tolerance in the adult: The interaction between myeloablation and immunosuppression. Eur. J. Immunol. 1992. 22: 2825-2830.
23. Doody, D. P., Stenger, K. S. and Winn, H. J., Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts. J. Exp. Med. 1994. 179: 1645-1652.
24. Braun, M. Y., Grandjean, L, Feunou, P., Duban, L., Kiss, R., Goldman, M. and Lantz, O., Acute rejection in the absence of cognate recognition of allograft by T cells. J. Immunol. 2001. 166: 4879-4883.
25. Boyse, E. A., Carswell, E. A., Scheid, M. P. and Old, L. J., Tolerance of Skin-compatible skin grafts. Nature 1973. 244: 441-442.
26. Boyse, E. A., Lance, E. M., Carswell, E. A., Cooper, S. and Old, L. J., Rejection of skin allografts by radiation chimaeras: Selective gene action in the specification of cell surface structure. Nature 1970. 227: 901-903.
27. Boyse, E. A. and Old, L. J., Loss of skin allograft tolerance by chimeras. Transplantation 1968. 6: 619.
28. Oehen, S. and Brduscha-Riem, K., Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J. Immunol. 1998. 161: 5338-5346.
29. Fuchimoto, Y., Gleit, Z. L., Huang, C. A., Kitamura, H., Schwarze, M. L., Menard, M. T., Mawulawde, K. et al., Skin-specific alloantigens in miniature swine. Transplantation 2001. 72: 122-126.
30. Taylor, P. A., Lees, C. J., Waldmann, H., Noelle, R. J. and Blazar, B. R., Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood 2001. 98: 467-474.
31. Silverman, M. S. and Chin, P. H., Differences in the rejection of skin transplants and blood cells of donor marrow origin by radiation-induced chimeras. Ann. N. Y. Acad. Sci. 1962. 99: 542-549.
32. Steinmuller, D., Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts sill is an enigma. Transplantation 2001. 72: 8-9.
33. Markees, T. G., Phillips, N. E., Gordon, E. J., Noelle, R. J., Shultz, L. D., Mordes, J. P., Greiner, D. L. and Rossini, A. A., Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 1998. 101: 2446-2455.
34. Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J. and Waldmann, H., "Infectious" transplantation tolerance. Science 1993. 259: 974-977.
35. Qin, S. X., Wise, M., Cobbold, S. P., Leong, L., Kong, Y. C., Parnes, J. R. and Waldmann, H., Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 1990. 20: 2737-2745.
36. Bemelman, F., Honey, K., Adams, E., Cobbold, S. and Waldmann, H., Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J. Immunol. 1998. 160: 2645-2648.
37. Graca, L., Daley, S., Fairchild, P. J., Cobbold, S. P. and Waldmann, H., Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning. BMC Immunol. 2006. 7: 9.
38. Wekerle, T., Sayegh, M. H., Hill, J., Zhao, Y., Chandraker, A., Swenson, K.G., Zhao, G. and Sykes, M., Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 1998. 187: 2037-2044.
39. Wekerle, T., Kurtz, J., Ito, H., Ronquillo, J. V., Dong, V., Zhao, G., Shaffer, J. et al., Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 2000. 6: 464-469.
40. Colson, Y. L., Schuchert, M. J. and Ildstad, S. T., The abrogation of allosensitization following the induction of mixed allogeneic chimerism. J. Immunol. 2000. 165: 637-644.
41. Russell, P. S., Chase, C. M., Sykes, M., Ito, H., Shaffer, J. and Colvin, R. B., Tolerance, mixed chimerism, and chronic transplant arteriopathy. J. Immunol. 2001. 167: 5731-5740.
42. Umemura, A., Morita, H., Li, X. C., Tahan, S., Monaco, A. P. and Maki, T., Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J. Immunol. 2001. 167: 3043-3048.
43. Eto, M., Hackstein, H., Kaneko, K., Nomoto, K. and Thomson, A. W., Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions. J. Immunol. 2002. 169: 2390-2396.
44. van Pel, M., van Breugel, D. W., Vos, W., Ploemacher, R. E. and Boog, C. J., Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers. Bone Marrow Transplant. 2004. 33: 153-159.
45. Hale, D. A., Gottschalk, R., Umemura, A., Maki, T. and Monaco, A. P., Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow. Transplantation 2002. 74: 477-484.
46. Taylor, P. A., Lees, C. J., Wilson, J. M., Ehrhardt, M. J., Campbell, M. T., Noelle, R. J. and Blazar, B. R., Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 2002. 100: 3400-3407.
47. Blaha, P., Bigenzahn, S., Koporc, Z., Schmid, M., Langer, F., Selzer, E., Bergmeister, H. et al., The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation b lockade. Blood 2003. 101: 2886-2893.
48. Pan, Y., Luo, B., Sozen, H., Kalscheuer, H., Blazar, B. R., Sutherland, D. E., Hering, B. J. and Guo, Z., Blockade of the CD40/ CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy. Transplantation 2003. 76: 216-224.
49. 153 Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness. Transplantation 2004. 77: 647-655.
50. Lee, E. N., Lee, J., Kim, E. Y., Park, H. J., Chang, C. Y., Jung, D. Y., Choi, S. Y. et al., Tolerance induction through megadose bone marrow transplantation with two-signal blockade. J. Surg. Res. 2006. 130: 102-109.
51. West, L. J. and Tao, K., Acceptance of third-party cardiac but not skin allografts induced by neonatal exposure to semi-allogeneic lymphohematopoietic cells. Am. J. Transplant. 2002. 2: 733-744.
52. Koretz, S. H., Gottlieb, M. S., Strober, S., Pennock, J., Bieber, C. P., Hoppe, R. T., Reitz, B. A. and Kaplan, H. S., Organ transplantation in mongrel dogs using total lymphoid irradiation (TLI). Transplant. Proc. 1981. 13: 443-445.
53. Fudaba, Y., Spitzer, T. R., Shaffer, J., Kawai, T., Fehr, T., Delmonico, F., Preffer, F. et al., Myeloma responses and tolerance following combined kidney and nomnyeloablative marrow transplantation: in vivo and in vitro analyses. Am. J. Transplant. 2006. 6: 2121-2133.
54. Rose, N. R., Metzgar, R. S. and Witebsky, E., Studies on organ specificity. X1. Isoantigens of rabbit pancreas. J. Immunol. 1960. 85: 575-587.
55. Beilhack, G. F., Scheffold, Y. C., Weissman, I. L., Taylor, C., Jerabek, L., Burge, M. J., Masek, M. A. and Shizuru, J. A., Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003. 52: 59-68.
56. Ildstad, S. T., Wren, S. M., Sharrow, S. O., Stephany, D. and Sachs, D. H., In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10 + F344 rat→B10). J. Exp. Med. 1984. 160: 1820-1835.
57. Ildstad, S. T., Wren, S. M. and Hronakes, M. L., Cross-species bone marrow transplantation: Evidence for recognition of skin-specific antigens across a species barrier (rat→mouse). J. Surg. Res. 1991. 51: 372-376.
58. Ildstad, S. T., Boggs, S. S., Vecchini, F., Wren, S. M., Hronakes, M. L., Johnson, P. C. and Van den Brink, M. R., Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens. Transplantation 1992. 53: 815-822.